Stem Pharm, Inc
Stem Pharm - Advanced Neural Organoids Models
FromStem Pharm, Inc
Stem Pharm’s advanced neural organoid models uniquely contain microglia and provide new opportunities to investigate CNS disease modeling, drug discovery, and toxicology applications.
Most popular related searches
stem cell ipsc
human stem cell-derived
disease modeling
drug discovery
stem cell
stem cell derived
cytokine chemokine
drug industry
cytokine expressing
cytokine expression
Our organoids can be used to:
- Unravel disease complexity
- Assess functionality
- Discover new targets
- Perform phenotypic screens
- Evaluate toxicity
Areas of Relevance:
- Neuroinflammation
- Neurodegeneration
- Neurogenesis
- Neurodevelopmental diseases
Stem Pharm neural organoids more closely resemble the physiology of human neural tissue by including vascular and immune components in addition to neurons.
- Enabled by Stem Pharm hydrogels
- Human stem cell (iPSC) derived
- Broad representation of neural subtypes
- Scalable and reproducible
- 96-well plate format
The 96-well plate open format of our organoids allows us to analyze multimodal outputs including:
- Multi-omics (RNA, protein, metabolites)
- Cytokine and chemokine expression
- Imaging
These data outputs drive insights into disease biology and target selection as well as elucidate toxicologic effects of drugs and industrial chemicals.